210 related articles for article (PubMed ID: 16892077)
1. Mitochondria in cancer.
Kroemer G
Oncogene; 2006 Aug; 25(34):4630-2. PubMed ID: 16892077
[TBL] [Abstract][Full Text] [Related]
2. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer.
King A; Selak MA; Gottlieb E
Oncogene; 2006 Aug; 25(34):4675-82. PubMed ID: 16892081
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria in cancer cells: what is so special about them?
Gogvadze V; Orrenius S; Zhivotovsky B
Trends Cell Biol; 2008 Apr; 18(4):165-73. PubMed ID: 18296052
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria in cancer: not just innocent bystanders.
Frezza C; Gottlieb E
Semin Cancer Biol; 2009 Feb; 19(1):4-11. PubMed ID: 19101633
[TBL] [Abstract][Full Text] [Related]
5. Warburg tumours and the mechanisms of mitochondrial tumour suppressor genes. Barking up the right tree?
Bayley JP; Devilee P
Curr Opin Genet Dev; 2010 Jun; 20(3):324-9. PubMed ID: 20304625
[TBL] [Abstract][Full Text] [Related]
6. The Warburg effect and mitochondrial stability in cancer cells.
Gogvadze V; Zhivotovsky B; Orrenius S
Mol Aspects Med; 2010 Feb; 31(1):60-74. PubMed ID: 19995572
[TBL] [Abstract][Full Text] [Related]
7. Electron microscopy morphology of the mitochondrial network in human cancer.
Arismendi-Morillo G
Int J Biochem Cell Biol; 2009 Oct; 41(10):2062-8. PubMed ID: 19703662
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria as therapeutic targets for cancer chemotherapy.
Galluzzi L; Larochette N; Zamzami N; Kroemer G
Oncogene; 2006 Aug; 25(34):4812-30. PubMed ID: 16892093
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial mutations in cancer.
Brandon M; Baldi P; Wallace DC
Oncogene; 2006 Aug; 25(34):4647-62. PubMed ID: 16892079
[TBL] [Abstract][Full Text] [Related]
10. Glucose avidity of carcinomas.
Ortega AD; Sánchez-Aragó M; Giner-Sánchez D; Sánchez-Cenizo L; Willers I; Cuezva JM
Cancer Lett; 2009 Apr; 276(2):125-35. PubMed ID: 18790562
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
12. Why do cancers have high aerobic glycolysis?
Gatenby RA; Gillies RJ
Nat Rev Cancer; 2004 Nov; 4(11):891-9. PubMed ID: 15516961
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria as targets for cancer chemotherapy.
Gogvadze V; Orrenius S; Zhivotovsky B
Semin Cancer Biol; 2009 Feb; 19(1):57-66. PubMed ID: 19101636
[TBL] [Abstract][Full Text] [Related]
14. Targeting mitochondria as a therapeutic target in cancer.
Wenner CE
J Cell Physiol; 2012 Feb; 227(2):450-6. PubMed ID: 21503875
[TBL] [Abstract][Full Text] [Related]
15. Reprogramming of tumor metabolism by targeting mitochondria improves tumor response to irradiation.
Bol V; Bol A; Bouzin C; Labar D; Lee JA; Janssens G; Porporato PE; Sonveaux P; Feron O; Grégoire V
Acta Oncol; 2015 Feb; 54(2):266-74. PubMed ID: 25007226
[TBL] [Abstract][Full Text] [Related]
16. Cellular life span and the Warburg effect.
Kondoh H
Exp Cell Res; 2008 Jun; 314(9):1923-8. PubMed ID: 18410925
[TBL] [Abstract][Full Text] [Related]
17. A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma.
Ndozangue-Touriguine O; Sebbagh M; Mérino D; Micheau O; Bertoglio J; Bréard J
Oncogene; 2008 Oct; 27(46):6012-22. PubMed ID: 18560353
[TBL] [Abstract][Full Text] [Related]
18. Targeting mitochondrial permeability in cancer drug development.
Berridge MV; Herst PM; Lawen A
Mol Nutr Food Res; 2009 Jan; 53(1):76-86. PubMed ID: 19035550
[TBL] [Abstract][Full Text] [Related]
19. Glycolytic enzyme upregulation and numbness of mitochondrial activity characterize the early phase of apoptosis in cerebellar granule cells.
Bobba A; Amadoro G; La Piana G; Calissano P; Atlante A
Apoptosis; 2015 Jan; 20(1):10-28. PubMed ID: 25351440
[TBL] [Abstract][Full Text] [Related]
20. Selective amino acid restriction targets mitochondria to induce apoptosis of androgen-independent prostate cancer cells.
Fu YM; Zhang H; Ding M; Li YQ; Fu X; Yu ZX; Meadows GG
J Cell Physiol; 2006 Nov; 209(2):522-34. PubMed ID: 16897757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
